We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Golub Capital BDC
GBDC
$3.42B
| $2.04M | ﹤0.01% |
122,789
-558,917
| -82% | -$8.73M |
|
|
PGRE
1427
DELISTED
Paramount Group
PGRE
| $2.04M | ﹤0.01% |
435,092
+335,461
| +337% | +$1.58M |
|
|
SCHW
1428
Charles Schwab
SCHW
$187B
| $2.04M | ﹤0.01% |
28,200
| – | – |
|
1429
M/I Homes
MHO
$3.84B
| $2.04M | ﹤0.01% |
14,960
-3,998
| -21% | -$508K |
|
1430
W.W. Grainger
GWW
$60.2B
| $2.03M | ﹤0.01% |
2,000
| – | – |
|
|
WRK
1431
DELISTED
WestRock Company
WRK
| $2.03M | ﹤0.01% |
41,021
-46,176
| -53% | -$2.02M |
|
1432
Oneok
OKE
$54.5B
| $2.02M | ﹤0.01% |
25,256
| – | – |
|
1433
IBM
IBM
$224B
| $2.02M | ﹤0.01% |
10,600
-113,003
| -91% | -$20.6M |
|
1434
Celestica
CLS
$36.5B
| $2.02M | ﹤0.01% |
45,041
-150,508
| -77% | -$5.71M |
|
1435
Acadia Pharmaceuticals
ACAD
$5.03B
| $2.02M | ﹤0.01% |
109,429
-239,299
| -69% | -$5.93M |
|
1436
Darling Ingredients
DAR
$9.44B
| $2.02M | ﹤0.01% |
43,431
+14,431
| +50% | +$635K |
|
|
EARN
1437
Ellington Residential Mortgage REIT
EARN
$165M
| $2.02M | ﹤0.01% |
291,919
-27,600
| -9% | -$170K |
|
1438
Hertz
HTZ
$809M
| $2.02M | ﹤0.01% |
257,583
-52,445
| -17% | -$429K |
|
1439
Clover Health Investments
CLOV
$2.51B
| $2.01M | ﹤0.01% |
2,525,895
-1,104,604
| -30% | -$1.01M |
|
1440
Rocket Companies
RKT
$38.9B
| $2M | ﹤0.01% |
137,645
-31,100
| -18% | -$386K |
|
1441
Southwest Airlines
LUV
$23B
| $2M | ﹤0.01% |
68,450
-96,460
| -58% | -$2.99M |
|
1442
FS KKR Capital
FSK
$3.44B
| $1.99M | ﹤0.01% |
104,416
-1,023,836
| -91% | -$20.3M |
|
1443
Hilton Grand Vacations
HGV
$3.55B
| $1.99M | ﹤0.01% |
42,167
-33,970
| -45% | -$1.49M |
|
1444
Cohu
COHU
$2.5B
| $1.99M | ﹤0.01% |
59,668
+3,555
| +6% | +$116K |
|
|
CWAN
1445
DELISTED
Clearwater Analytics
CWAN
| $1.99M | ﹤0.01% |
112,374
-586,841
| -84% | -$10.9M |
|
1446
Marriott International
MAR
$92.3B
| $1.99M | ﹤0.01% |
7,875
+6,725
| +585% | +$1.63M |
|
1447
Illinois Tool Works
ITW
$84.5B
| $1.98M | ﹤0.01% |
7,388
+288
| +4% | +$74.8K |
|
1448
Twilio
TWLO
$36.6B
| $1.98M | ﹤0.01% |
32,404
-670,701
| -95% | -$44.2M |
|
1449
National Health Investors
NHI
$3.65B
| $1.98M | ﹤0.01% |
31,475
-5,138
| -14% | -$290K |
|
1450
DXP Enterprises
DXPE
$2.98B
| $1.98M | ﹤0.01% |
36,758
-19,427
| -35% | -$730K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.